1 / 6

Analysis of Pharmacovigilance market by 2026

Pharmacovigilance industry analysis is covered in this latest research report that aims to help those taking daily business decisions by providing market trends information, competitive landscape scenario, forecasts and more.

Nikhil_Saro
Télécharger la présentation

Analysis of Pharmacovigilance market by 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharmacovigilance Market trends research and projections for 2019- 2025 • As per a research report by Global Market Insights, Inc., global pharmacovigilance market is estimated to surpass $8.9 billion by 2025. • With growing consumption of drugs and rising concerns regarding adverse effects of drugs across the world, the global pharmacovigilance market size is projected to witness a lucrative rate of growth over the forthcoming time period. Factors such as growing accessibility to drugs, increasing number of chronic diseases and rising per capita healthcare expenditure in several countries across the world will further impact the industry growth. • As per reports presented by the CDC (Centers for Disease Control and Prevention), in 2017, approximately 28,000 deaths occurred owing to synthetic opioids consumption in the United States. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  2. Meanwhile, use of personalized medicines has also increased profoundly, especially in developed nations. Additionally, the adoption of gene therapy for treating various types of cancer and other chronic diseases, has further led to demand for personalized medicines over the forthcoming years. • Advancements in precision as well as personalized medicine are further anticipated to offer solutions to individuals by taking into consideration their reactions to medicine and composition of genes. Innovations as well as growing acceptance of personalized medicine will likely surge the need for pharmacovigilance practices further. • The clinical trial phases segment is bifurcated into phase IV, phase III, phase II, phase I, and preclinical studies. The phase IV segment accounted a revenue share of over 70% in 2018. Pharmacovigilance is crucial for safety surveillance after the drug has been released in the market. • Pharmacovigilance detects and further reports harmful effects along with adverse drug reactions (ADRs), which may result in restricted use in certain patients or even discontinuation of drugs. Hence, increasing number of pharmaceutical companies focused towards new drug development will lay a positive impact in the market. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  3. Request for a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/853 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  4. Regional Analysis • Furthermore, segmental growth can also be fueled by companies having developed infrastructure as well as skilled staff. • On the geographical front, the Europe pharmacovigilance market is expected to witnessed a CAGR of 9.5% during the forecast timeline. Practices such as harmonization and centralization of pharmacovigilance will further prove to be effective for the observation of safety signals in the region. • Moreover, since 2012, rules imposed in the EU, have led to increased involvement of patients and professionals in the PRAC (Pharmacovigilance and Risk Assessment Committee). Furthermore, advancements in personalized medicines are further set to offer numerous opportunities for the growth of regional market. • Competitive Analysis • The competitive landscape of global pharmacovigilance market includes companies like IQVIA, F. Hoffmann-La Roche Ltd, ICON, Cognizant, Clinquest Group, Infosys Ltd, EcronAcunova Ltd, HCL Technologies, Boehringer Ingelheim, GlaxoSmithKline, Bristol-Myers Squibb, Accenture and IBM Corporation among others. Make An Inquiry To Purchase This Report @ https://www.gminsights.com/inquiry-before-buying/853 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  5. Latest Research Report On U.S. Home Remodeling Market @ https://www.gminsights.com/industry-analysis/pharmacovigilance-market Request for sample of this research report@ https://www.gminsights.com/request-sample/detail/853 Request for customization: https://www.gminsights.com/roc/853 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  6. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com www.gminsights.com

More Related